There is a need to better understand and predict postsurgical outcomes for degenerative cervical myelopathy (DCM) patients, particularly to support treatment decisions for patients with mild DCM. The goal of this study was to identify and predict outcome trajectories for DCM patients up to 2 years postsurgery.
The authors analyzed two North American multicenter prospective DCM studies (n = 757). Functional recovery and physical health component quality of life were assessed in DCM patients at baseline, 6 months, and 1 and 2 years postoperatively using the modified Japanese Orthopaedic Association (mJOA) score and Physical Component Summary (PCS) of the SF-36, respectively. Group-based trajectory modeling was used to identify recovery trajectories for mild, moderate, and severe DCM. Prediction models for recovery trajectories were developed and validated in bootstrap resamples.
Two recovery trajectories were identified for the functional and physical components of quality of life: good recovery and marginal recovery. Depending on outcome and myelopathy severity, one-half to three-fourths of the study patients followed the good recovery trajectory characterized by improvement in mJOA and PCS scores over time. The remaining one-half to one-fourth of patients followed the marginal recovery trajectory, experiencing little improvement and, in certain cases, worsening postoperatively. The prediction model for mild DCM had an area under the curve of 0.72 (95% CI 0.65–0.80), with preoperative neck pain, smoking, and posterior surgical approach noted as dominant predictors of marginal recovery.
Surgically treated DCM patients follow distinct recovery trajectories in the first 2 years postoperatively. While most patients experience substantial improvement, a significant minority experience little improvement or worsening. The ability to predict DCM patient recovery trajectories in the preoperative setting facilitates the formulation of individualized treatment recommendations for patients with mild symptoms.
Approaching the debate of laminectomy versus fusion for grade 1 lumbar spondylolisthesis, the authors leveraged simulation to show how differences between the fusion groups of landmark randomized control trials (RCTs) led to seemingly divergent conclusions, and they offer insights into the design of future RCTs. Lami = laminectomy alone; SLIP = Spinal Laminectomy versus Instrumented Pedicle Screw. See the article in this issue by Meade et al. (pp 696–704). Reprinted with permission, Cleveland Clinic Foundation ©2023. All rights reserved.
INCLUDE WHEN CITINGPublished online March 17, 2023; DOI: 10.3171/2023.1.SPINE221053.
DisclosuresDr. Wilson reported personal fees from Stryker Canada outside the submitted work. Dr. Witiw reported personal fees from Cerapedics Inc. and Stryker outside the submitted work.
Kalsi-RyanS,KaradimasSK,FehlingsMG.Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder.Neuroscientist.2013;19(4):409–421.
BadhiwalaJH,AhujaCS,AkbarMA,et al.Degenerative cervical myelopathy—update and future directions.Nat Rev Neurol.2020;16(2):108–124.
NouriA,TetreaultL,SinghA,KaradimasSK,FehlingsMG.Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis.Spine (Phila Pa 1976).2015;40(12):E675–E693.
WilsonJR,TetreaultLA,KimJ,et al.State of the art in degenerative cervical myelopathy: an update on current clinical evidence.开云体育app官方网站下载入口.2017;80(3S):S33–S45.
FehlingsMG,TetreaultLA,RiewKD,MiddletonJW,WangJC.A clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scope.Global Spine J.2017;7(3 suppl):21S–27S.
RheeJ,TetreaultLA,ChapmanJR,et al.Nonoperative versus operative management for the treatment degenerative cervical myelopathy: an updated systematic review.Global Spine J.2017;7(3 suppl):35S–41S.
FehlingsMG,TetreaultLA,RiewKD,et al.A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression.Global Spine J.2017;7(3 suppl):70S–83S.
FehlingsMG,IbrahimA,TetreaultL,et al.A global perspective on the outcomes of surgical decompression in patients with cervical spondylotic myelopathy: results from the prospective multicenter AOSpine international study on 479 patients.Spine (Phila Pa 1976).2015;40(17):1322–1328.
FehlingsMG,WilsonJR,KopjarB,et al.Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study.中华骨科杂志.2013;95(18):1651–1658.
TetreaultLA,KopjarB,VaccaroA,et al.A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.中华骨科杂志.2013;95(18):1659–1666.
TetreaultLA,CôtéP,KopjarB,ArnoldP,FehlingsMG.A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients.Spine J.2015;15(3):388–397.
EvaniewN,Charest-MorinR,JacobsWB,et al.Cervical sagittal alignment in patients with cervical spondylotic myelopathy: an observational study from the Canadian Spine Outcomes and Research Network.Spine (Phila Pa 1976).2022;47(5):E177–E186.
NaginDS,OdgersCL.Group-based trajectory modeling in clinical research.Annu Rev Clin Psychol.2010;6:109–138.
SteyerbergEW.Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating.2nd ed.Springer Nature;2019.
KarimSM,CadotteDW,WilsonJR,et al.在病人手术减压的有效性s with degenerative cervical myelopathy: results of the Canadian prospective multicenter study.开云体育app官方网站下载入口.2021;89(5):844–851.
EvaniewN,CadotteDW,DeaN,et al.Clinical predictors of achieving the minimal clinically important difference after surgery for cervical spondylotic myelopathy: an external validation study from the Canadian Spine Outcomes and Research Network.J Neurosurg Spine.2020;33(2):129–137.
TetreaultL,WilsonJR,KotterMR,et al.Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy.Neurosurg Focus.2016;40(6):E14.
TetreaultLA,ZhuMP,HowardRM,et al.The discrepancy between functional outcome and self-reported health status after surgery for degenerative cervical myelopathy.Spine J.2019;19(11):1809–1815.
BadhiwalaJH,赫克曼于LD,MeraliZ,et al.Predicting outcomes after surgical decompression for mild degenerative cervical myelopathy: moving beyond the mJOA to identify surgical candidates.开云体育app官方网站下载入口.2020;86(4):565–573.
GhogawalaZ,TerrinN,DunbarMR,et al.Effect of ventral vs dorsal spinal surgery on patient-reported physical functioning in patients with cervical spondylotic myelopathy: a randomized clinical trial.JAMA.2021;325(10):942–951.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 768 | 769 | 51 |
Full Text Views | 373 | 373 | 8 |
PDF Downloads | 323 | 323 | 13 |
EPUB Downloads | 0 | 0 | 0 |